Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP326822.RAbV6ojU-G9JDl-5pAsY30n7qoITRQsB9xf9nuzrvRfhw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP326822.RAbV6ojU-G9JDl-5pAsY30n7qoITRQsB9xf9nuzrvRfhw130_assertion type Assertion NP326822.RAbV6ojU-G9JDl-5pAsY30n7qoITRQsB9xf9nuzrvRfhw130_head.
- NP326822.RAbV6ojU-G9JDl-5pAsY30n7qoITRQsB9xf9nuzrvRfhw130_assertion wasGeneratedBy ECO_0000203 NP326822.RAbV6ojU-G9JDl-5pAsY30n7qoITRQsB9xf9nuzrvRfhw130_provenance.
- NP326822.RAbV6ojU-G9JDl-5pAsY30n7qoITRQsB9xf9nuzrvRfhw130_assertion wasDerivedFrom befree-20150227 NP326822.RAbV6ojU-G9JDl-5pAsY30n7qoITRQsB9xf9nuzrvRfhw130_provenance.
- NP326822.RAbV6ojU-G9JDl-5pAsY30n7qoITRQsB9xf9nuzrvRfhw130_assertion SIO_000772 24185104 NP326822.RAbV6ojU-G9JDl-5pAsY30n7qoITRQsB9xf9nuzrvRfhw130_provenance.
- NP326822.RAbV6ojU-G9JDl-5pAsY30n7qoITRQsB9xf9nuzrvRfhw130_assertion evidence source_evidence_literature NP326822.RAbV6ojU-G9JDl-5pAsY30n7qoITRQsB9xf9nuzrvRfhw130_provenance.
- NP326822.RAbV6ojU-G9JDl-5pAsY30n7qoITRQsB9xf9nuzrvRfhw130_assertion description "[14-3-3σ attenuates RhoGDI2-induced cisplatin resistance through activation of Erk and p38 in gastric cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP326822.RAbV6ojU-G9JDl-5pAsY30n7qoITRQsB9xf9nuzrvRfhw130_provenance.